Squarepoint’s Inspire Medical Systems INSP Stock Holding History

Squarepoint’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,300	Closed	-$212K	–	4593
2025 Q4	$212K	Buy	+2,300	New	+$220K	﹤0.01%	3828
2024 Q4	–	Sell	-12,700	Closed	-$2.68M	–	5255
2024 Q3	$2.68M	Sell	12,700 -11,500	-48%	-$2M	﹤0.01%	1871
2024 Q2	$3.24M	Sell	24,200 -31,300	-56%	-$5.92M	0.01%	1686
2024 Q1	$11.9M	Buy	55,500 +38,800	+232%	+$7.61M	0.02%	887
2023 Q4	$3.4M	Buy	+16,700	New	+$2.71M	0.01%	1642
2023 Q3	–	Sell	-4,700	Closed	-$1.53M	–	4011
2023 Q2	$1.53M	Buy	+4,700	New	+$1.34M	﹤0.01%	1861
2023 Q1	–	Sell	-2,200	Closed	-$554K	–	3479
2022 Q4	$554K	Hold	2,200	–	–	﹤0.01%	2219
2022 Q3	$390K	Buy	+2,200	New	+$442K	﹤0.01%	2329

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Squarepoint's INSP Position: Q1 2026 in Review

Squarepoint increased its Inspire Medical Systems (INSP) stake by 879% in Q1 2026, buying an estimated $4.2M and bringing the position to 66,814 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1778.

Squarepoint first reported a position in INSP in Q1 2019 and has held it in 23 quarters since. The position peaked at $11.1M in Q3 2023. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

Squarepoint held 66,814 shares of Inspire Medical Systems worth $3.45M as of Q1 2026.
Squarepoint bought 59,992 Inspire Medical Systems shares in Q1 2026, an estimated $4.2M.
Inspire Medical Systems made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1778 holding.
Squarepoint first reported a position in Inspire Medical Systems in Q1 2019 and has held it in 23 quarters since.
Squarepoint's Inspire Medical Systems position peaked at $11.1M in Q3 2023.
301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.